Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Lowers Price Target to $9

Benzinga Newsdesk www.benzinga.com Negative 85.5%

Neg 85.5% Neu 0% Pos 0%

Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and lowers the price target from $10 to $9.